Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 9
Submit an article Journal homepage
1,002
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease

Nobuharu Ohshimaa Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1959-1472View further author information
ORCID Icon,
Yukihiro Akedab Department of Infection Control and Prevention, Graduate School of Medicine, Osaka University, Osaka, JapanView further author information
,
Hideaki Nagaia Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, JapanView further author information
&
Kazunori Oishic Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan;d Department of Bacteriology, Toyama Institute of Health, Toyama, JapanView further author information
Pages 2285-2291 | Received 04 Nov 2019, Accepted 16 Jan 2020, Published online: 12 Feb 2020

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Allan W. Cripps, Temitope Folaranmi, Kelly D. Johnson, Luwy Musey, Michael S. Niederman & Ulrike K. Buchwald. (2021) Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature. Expert Review of Vaccines 20:3, pages 257-267.
Read now

Articles from other publishers (1)

Thundon Ngamprasertchai, Chayanis Kositamongkol, Saranath Lawpoolsri, Pinyo Rattanaumpawan, Viravarn Luvira, Piriyaporn Chongtrakool, Jaranit Kaewkungwal, Kulkanya Chokephaibulkit & Pochamana Phisalprapa. (2023) A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult. Frontiers in Public Health 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.